Medical Health & Life Science Research News

Recent research: Global migraine drug market to be growing at a CAGR of 4.87 %, to reach USD 4.90 billion by 2021

Recent research: Global migraine drug market to be growing at a CAGR of 4.87 %, to reach USD 4.90 billion by 2021

Global Migraine Drug Market By Treatment (Preventive And Absorptive) By Therapeutic Class (triptants, Ergots And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

- Advertising -

According to the Global Migraine Drug Market Forecast Report, the market was worth USD 3.86 billion in 2016 and estimated to be growing at a CAGR of 4.87 %, to reach USD 4.90 billion by 2021.There are two kinds of medications used to treat migraine. Some are used to cure migraine and some are used to prevent migrane. 

The following are the medicines used to cure migraine are Anticonvulsants, such as topiramate, Beta-blockers, such as propranolol, Antihistamine, such as cyproheptadine, Botulinum toxin, Histamine, Calcium channel blockers, such as verapamil.   

Download Free Sample Report @ www.marketdataforecast.com/market-…03/request-sample

One of the vital drivers for this market is the developing awareness about types of headache and its treatment alternatives.

- Advertising -

Due to the developing rate of headache and the increase of high neglected needs in this market, a few organizations have begun putting resources into the R&D of headache drugs, which will help in developing prospects for this market.

Access Report @ www.marketdataforecast.com/cart/bu…drug-market-4103/

The expanding requirement for new treatment choices has encouraged to the improvement of new devices, for example, ant migraine devices and headbands in the market. Coaly Transcutaneous Electrical Nerve Stimulation devices is a FDA confirmed devices for headache treatment.

This device stimulates the trigeminal nerve with electric streams and gives relief from headache. Increasing of practicing new research exercises and novel item advancements are based on development and improvement of this market throughout the following four years.

Global Migraine Drug Market Segmentation:

By Treatment

  • Preventive
  • Absorptive

By Therapeutic class

  • Triptants
  • ergots
  • others

By Region

  • North America
  • Asia-Pacific
  • Latin America
  • Europe
  • Middle East and Africa

Migraine Drug Market Key players are Allergan, GlaxoSmithKline, Pfizer, Endo, Impax Laboratories. The other prominent vendors the market include AbbottAeriel BioPharma, Alder Biopharmaceuticals, Amgen, Astellas, Bayer, CoLucid, Eli Lilly, IntelGenx, Ethypharm, Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, AstraZeneca, Meda, Dr.

Reddy's Laboratories,  OptiNose, Pozen,Eisai, Raptor, RedHill, SUDA, Teva, , Aegis Therapeutics, Merck, TG Therapeutics, NValeant, Winston Pharmaceuticals, Allergan,  and Zogenix.

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...